
Alibaba's e-commerce remains its core growth engine, with Taobao and Tmall customer management revenues rising 12% and the group's overall revenue at RMB 93.2 billion (+4% YoY) in Q4 FY25, while international commerce, driven by AliExpress, surged 45% to RMB 27.4 billion. Alibaba is strategically integrating services like Ele.me and Fliggy and leveraging AI to enhance user experience and monetization amidst fierce competition from JD.com and PDD Holdings. Despite these challenges, BABA shares have gained 34.4% YTD, outperforming the industry, and trade at a forward P/E of 10.39x, significantly below the industry average, signaling investor confidence in its strategic focus and valuation.
Alibaba's strategic refocus on its core e-commerce operations is yielding tangible results, headlined by a significant 45% year-over-year surge in international commerce revenue to RMB 27.4 billion in Q4 FY25. While the domestic Taobao and Tmall Group posted more modest revenue growth of 4% to RMB 93.2 billion, a 12% increase in customer management revenues points to successful monetization improvements through higher take rates and enhanced AI tools. The company is actively fortifying its ecosystem by integrating its food delivery (Ele.me) and travel (Fliggy) platforms to create a more comprehensive consumer-centric service. This strategic pivot occurs amidst intense domestic competition from JD.com and PDD Holdings, which reported strong respective revenue growth of 16.3% and 15% in their recent quarters. Despite this competitive pressure, Alibaba's stock has outperformed its industry year-to-date with a 34.4% gain, yet it trades at a compelling forward P/E ratio of 10.39X, substantially below the industry average of 24.70X, suggesting the market is still pricing in a significant discount relative to its peers and its positive earnings growth forecasts.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment